4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-21-123186
SVP, Chief Scientific Officer sold 50,000 shares at $4.89 ($244,500)
- SVP, Chief Scientific Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Abrahmsen Lars B. · SVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-01 | Exercise or conversion : show line 1 in the form | +50,000 | $0.92 | $46,000 | 69,000 | D |
| 2021-10-01 | Sale : show line 2 in the form | −50,000 | $4.89 | $244,500 | 19,000 | D |
| Open-market sales · 50,000 sh · avg $4.89 · $244,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-01 | Exercise or conversion : show line 3 in the form Stock Option (right to Buy) | −50,000 | 30,587 | D |
Loading xslF345X03/tm2129205-2_4seq1.xml…